eMedicals Healthtech
eMedicals Healthtech GmbH, founded in 2020 and based in Frankfurt am Main, Germany, operates at the intersection of life sciences and healthtech. The company develops a biochemical platform for novel therapeutics and AI solutions targeting Nutrition-Sensitive Diseases such as Chronic Kidney Disease, Cardiovascular Disease, and Type 2 Diabetes. Their platform, kidi, serves multiple stakeholders including patients, clinicians, insurers, and pharma by enabling diet and medication management, clinical decision support, cost savings, and innovative drug delivery via food. The company has secured funding from German federal and state research programs and angel investors, highlighting strong support for its innovative approach in nutrigenomics and neuro-symbolic AI technologies.
eMedicals Healthtech
eMedicals Healthtech GmbH, founded in 2020 and based in Frankfurt am Main, Germany, operates at the intersection of life sciences and healthtech. The company develops a biochemical platform for novel therapeutics and AI solutions targeting Nutrition-Sensitive Diseases such as Chronic Kidney Disease, Cardiovascular Disease, and Type 2 Diabetes. Their platform, kidi, serves multiple stakeholders including patients, clinicians, insurers, and pharma by enabling diet and medication management, clinical decision support, cost savings, and innovative drug delivery via food. The company has secured funding from German federal and state research programs and angel investors, highlighting strong support for its innovative approach in nutrigenomics and neuro-symbolic AI technologies.